BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 28347811)

  • 1. Whole blood coagulation assays ROTEM and T-TAS to monitor dabigatran treatment.
    Taune V; Wallén H; Ågren A; Gryfelt G; Sjövik C; Wintler AM; Malmström RE; Wikman A; Skeppholm M
    Thromb Res; 2017 May; 153():76-82. PubMed ID: 28347811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Dabigatran Treatment on Rotation Thromboelastometry.
    Sokol J; Nehaj F; Ivankova J; Mokan M; Zolkova J; Lisa L; Linekova L; Mokan M; Stasko J
    Clin Appl Thromb Hemost; 2021; 27():1076029620983902. PubMed ID: 33523711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid determination of anticoagulating effects of dabigatran in whole blood with rotational thromboelastometry and a thrombin-based trigger.
    Taune V; Skeppholm M; Ågren A; Gryfelt G; Malmström RE; Wikman A; Van Ryn J; Wallén H
    J Thromb Haemost; 2018 Dec; 16(12):2462-2470. PubMed ID: 30288934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the monitoring of dabigatran treatment in "real life" patients with atrial fibrillation.
    Skeppholm M; Hjemdahl P; Antovic JP; Muhrbeck J; Eintrei J; Rönquist-Nii Y; Pohanka A; Beck O; Malmström RE
    Thromb Res; 2014 Oct; 134(4):783-9. PubMed ID: 25172669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombelastography detects dabigatran at therapeutic concentrations in vitro to the same extent as gold-standard tests.
    Solbeck S; Ostrowski SR; Stensballe J; Johansson PI
    Int J Cardiol; 2016 Apr; 208():14-8. PubMed ID: 26826624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of dabigatran on platelet function and fibrinolysis.
    Tsantes AE; Kyriakou E; Bonovas S; Chondrogianni M; Zompola C; Liantinioti C; Simitsi A; Katsanos AH; Atta M; Ikonomidis I; Kapsimali V; Kopterides P; Tsivgoulis G
    J Neurol Sci; 2015 Oct; 357(1-2):204-8. PubMed ID: 26219486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dabigatran Concentration: Variability and Potential Bleeding Prediction In "Real-Life" Patients With Atrial Fibrillation.
    Šinigoj P; Malmström RE; Vene N; Rönquist-Nii Y; Božič-Mijovski M; Pohanka A; Antovic JP; Mavri A
    Basic Clin Pharmacol Toxicol; 2015 Nov; 117(5):323-9. PubMed ID: 25981948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Dabigatran on Clotting Time in the Clotpro Ecarin Clotting Assay: A Prospective, Single-Arm, Open-Label Study.
    Fong AYY; Tiong LL; Tan SSN; Geruka D; Apil GG; Choo CW; Ong TK
    Clin Appl Thromb Hemost; 2020; 26():1076029620972473. PubMed ID: 33284050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of dabigatran on thrombin generation and coagulation assays in rabbit and human plasma.
    Zhang C; Zhang P; Li H; Han L; Zhang L; Zhang L; Yang X
    Thromb Res; 2018 May; 165():38-43. PubMed ID: 29558660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global thromboelastometry in patients receiving direct oral anticoagulants: the RO-DOA study.
    Vedovati MC; Mosconi MG; Isidori F; Agnelli G; Becattini C
    J Thromb Thrombolysis; 2020 Feb; 49(2):251-258. PubMed ID: 31520364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole Blood Point-of-Care Testing for Incomplete Reversal With Idarucizumab in Supratherapeutic Dabigatran.
    Takeshita S; Tanaka KA; Sawa T; Sanda M; Mizobe T; Ogawa S
    Anesth Analg; 2020 Feb; 130(2):535-541. PubMed ID: 31490820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of reference intervals for single vial rotational thromboelastometry (ROTEM) parameters and correlation with plasmatic coagulation times in 49 clinically healthy dogs.
    Jud Schefer R; Heimgartner L; Stirn M; Sigrist NE
    Res Vet Sci; 2020 Apr; 129():129-136. PubMed ID: 31982776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anticoagulant effect of therapeutic levels of dabigatran in atrial fibrillation evaluated by thrombelastography (TEG
    Solbeck S; Jensen AS; Maschmann C; Stensballe J; Ostrowski SR; Johansson PI
    Scand J Clin Lab Invest; 2018; 78(1-2):25-30. PubMed ID: 29304563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of laboratory coagulation tests and clotting factor levels on Rotation Thromboelastometry (ROTEM(R)) during major surgery with hemorrhage.
    Theusinger OM; Schröder CM; Eismon J; Emmert MY; Seifert B; Spahn DR; Baulig W
    Anesth Analg; 2013 Aug; 117(2):314-21. PubMed ID: 23780419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of tissue factor and kaolin on blood coagulation assays using rotational thromboelastometry and thromboelastography.
    Peng HT; Grodecki R; Rizoli S; Shek PN
    Blood Coagul Fibrinolysis; 2016 Jan; 27(1):31-41. PubMed ID: 26340454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real life dabigatran and metabolite concentrations, focused on inter-patient variability and assay differences in patients with atrial fibrillation.
    Boonen K; Schmitz E; Rozestraten F; van den Heuvel D; Brunsveld L; van der Voort P; van de Kerkhof D
    Clin Chem Lab Med; 2017 Oct; 55(12):2002-2009. PubMed ID: 28328523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive characteristics of the anticoagulant activity of dabigatran in relation to its plasma concentration.
    Comuth WJ; Henriksen LØ; van de Kerkhof D; Husted SE; Kristensen SD; de Maat MPM; Münster AB
    Thromb Res; 2018 Apr; 164():32-39. PubMed ID: 29475179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world variability in dabigatran levels in patients with atrial fibrillation.
    Chan NC; Coppens M; Hirsh J; Ginsberg JS; Weitz JI; Vanassche T; Douketis JD; Schulman S; Eikelboom JW
    J Thromb Haemost; 2015 Mar; 13(3):353-9. PubMed ID: 25523236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific Point-of-Care Testing of Coagulation in Patients Treated with Dabigatran.
    Härtig F; Birschmann I; Peter A; Ebner M; Spencer C; Gramlich M; Richter H; Kuhn J; Lehmann R; Blumenstock G; Zuern CS; Ziemann U; Poli S
    Thromb Haemost; 2021 Jun; 121(6):782-791. PubMed ID: 33469905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of coagulation tests in patients on therapeutic doses of dabigatran: a cross-sectional pharmacodynamic study based on peak and trough plasma levels.
    Hawes EM; Deal AM; Funk-Adcock D; Gosselin R; Jeanneret C; Cook AM; Taylor JM; Whinna HC; Winkler AM; Moll S
    J Thromb Haemost; 2013 Aug; 11(8):1493-502. PubMed ID: 23718677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.